A. Eugene Washington - 06 Sep 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: Director
Issuer ticker: JNJ
Reported as of: 06 Sep 2022
Net transaction value: +$62,249
SEC form: 4
Accepted by SEC: 08 Sep 2022, 16:31:48 UTC
Prior SEC filing: 09 Jun 2022
Next SEC filing: 08 Dec 2022
Source filing: View source filing
Reporting owner signature: Raavi K. Deol, as attorney-in-fact for A. Eugene Washington

Key filing fact

A. Eugene Washington filed Form 4 for JOHNSON & JOHNSON (JNJ) on 08 Sep 2022.

Key facts

This page summarizes A. Eugene Washington's Form 4 filing for JOHNSON & JOHNSON (JNJ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Sep 2022, 16:31.

Change

Previous filing in this sequence was filed on 09 Jun 2022.
Current net transaction value: +$62,249.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Deferred Share Units

Award

Transaction value: $62,249
Shares: +379
Change %: +1.4%
Price: $164.11
Shares after: 27,812
Date: 06 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 379
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).